35,5 %Overall, 35.5% of women in the Mobile WAChX trial had incomplete visit coverage.
KenyaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 52 / 90
35,5 %Overall, 35.5% of women in the Mobile WAChX trial had incomplete visit coverage.
KenyaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations
4,3 %The prevalence of viral load non-suppression among treatment-experienced female sex workers in Kenya was 4.3% in 2021.
KenyaVIH/sidaobservé 2021publié 2025AIDS (London, England)PubMeddocument de 5 observations
30 %Antiretroviral therapy (ART) uptake among TB patients in Kenya increased from 30% in 2008 to 97% in 2018.
Kenyatuberculose · VIH/sidaobservé 2008publié 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument de 8 observations
17 %Malaria was present in 27 (17%) of 162 HIV-attributed infant or child deaths.
Kenyapaludisme · VIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations
11 patientsEleven patients had nucleoside reverse transcriptase inhibitor resistance mutations, including M184V and T215Y.
KenyaVIH/sidapublié 2022MedicinePubMeddocument de 7 observations
44,3 %The most common HIV testing points identifying HIV-positive children were outpatient departments (44.3%) and maternal/child health departments (29.9%).
KenyaVIH/sidaobservé 2017-2018publié 2020PloS onePubMeddocument de 8 observations
8,52 working_daysIn a centralised laboratory-only network, the mean turnaround time ranged from 8.52 to 8.55 working days.
KenyaVIH/sidapublié 2024BMJ openPubMeddocument de 6 observations
16,7 %Systems-level ED-based HIV testing among all presenting patients increased from 16.7% pre-implementation to 23.0% post-implementation periods 1 and 2.
KenyaVIH/sidaobservé 6 March - 16 April 2023 (pre-implementation); 1 May - 20 August 2023 (post-implementation periods 1 and 2)publié 2024HIV research & clinical practicePubMeddocument de 4 observations
0,73 adjusted_relative_riskAfter adjusting for age, the relative risk of PSA detection at postmenopausal versus premenopausal visits was 0.73 (95% confidence interval: 0.47 to 1.14).
KenyaVIH/sidapublié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 5 observations
59 daysTime to completion of at least 3 enhanced adherence counseling sessions was 59.0 days before implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublié 2022MedicinePubMeddocument de 12 observations
401 individualsBetween April 2022 and February 2023, 401 adolescent girls and young women were enrolled after initiating PrEP through their post-abortion care provider in Kenya.
KenyaVIH/sidaobservé April 2022 to February 2023publié 2024AIDS and behaviorPubMeddocument de 4 observations
944 partnersAmong 2176 partners in the post-implementation period, 944 were offered a second HIV self-test (HIVST).
KenyaVIH/sidaobservé March 2021-June 2022publié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations
The Tambua Mapema Plus study was conducted in Kenya from 2017 to 2020.
KenyaVIH/sidaobservé 2017-2020publié 2022BMJ openPubMeddocument de 8 observations
33,7 daysVihiga County had the shortest mean DNA-PCR turnaround time at 33.7 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.
KenyaVIH/sidaobservé January 2012 to June 2013publié 2024PloS onePubMeddocument de 7 observations
2,89 aHRAmong patients switching to dolutegravir-containing regimens, those without a recent viral load test or with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 2.89 for incident viral load ≥1000 copies/mL compared to those with preswitch viral load <200 copies/mL.
KenyaVIH/sidapublié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 6 observations
65 %In Kenya, the viral load testing uptake among paediatric and adolescent patients improved from 65% to 96%.
KenyaVIH/sidapublié 2021BMC health services researchPubMeddocument de 5 observations
11 prevalence_ratioThe prevalence ratio for experienced stigma associated with self-disclosure was 11.0 (95% CI: 1.4–86).
KenyaVIH/sidapublié 2021AIDS and behaviorPubMeddocument de 13 observations
82 %For 851 children eligible for testing, the most common reason for having an unknown HIV status was that the child's mother was not tested for HIV or had tested HIV negative during pregnancy (82%).
KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations
28,3 pg/mlThe median (IQR) levels of IFN-γ were 28.3 (23.5–31.2) pg/ml in pLLV participants and 11.4 (8.8–14.8) pg/ml in virally suppressed participants on first-line cART.
KenyaVIH/sidapublié 2025The Pan African medical journalPubMeddocument de 11 observations
22 yearsThe median age of 399 participants enrolling into an HIV incidence cohort in Kenya was 22 years, with an interquartile range of 19–24 years.
KenyaVIH/sidapublié 2024Journal of the International AIDS SocietyPubMeddocument de 6 observations
5 500 patientsOf the 5,500 people living with HIV aged ≥15 years on first-line antiretroviral therapy at one health facility in Kenya, 4,233 (77%) had transitioned to optimized antiretroviral drugs.
KenyaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations
22 %In 2013, 22% of participants in the African Cohort Study (AFRICOS) reported HIV stigma at the enrollment visit.
KenyaVIH/sidaobservé 2013publié 2022AIDS carePubMeddocument de 4 observations
1,11 aIRRIn the female sex worker cohort, there was no association between schistosomiasis and HIV-1 acquisition risk (adjusted incidence rate ratio = 1.11, 95% CI 0.83 to 1.50).
Kenyaschistosomiase · VIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 13 observations
1,2 %Among the studied cohort, the HIV positivity rate at initial test was 1.2%.
KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 11 observations
539 individuals539 (69%) of enrolled people living with HIV were female.
KenyaVIH/sidapublié 2022PloS onePubMeddocument de 15 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.